NSE · VIJAYA
Vijaya Diagnostic Centre Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹219 Cr with net profit ₹53 Cr — a 24.32% net margin, versus 25.56% the period before.
Shareholding
As of 2026-06-30
- Promoter52.51%
- Public4.23%
- FII11.66%
- DII31.61%
67,251 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.86× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Healthcare · ranked #13 of 85 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,27,048 Cr | 60.38 | 13.42 | 20.48% | 7.91% |
| Max Healthcare Institute Ltd. | ₹1,01,000 Cr | 67.47 | 9.4 | 13.42% | 16.73% |
| Manipal Health Enterpri Limited | ₹94,359 Cr | 100.61 | 5.73 | 10.59% | 7.81% |
| Fortis Healthcare Ltd. | ₹67,025 Cr | 62.83 | 6.77 | 10.53% | 11.02% |
| Aster DM Quality Care Ltd. | ₹66,652 Cr | 171.83 | 15.81 | 8.48% | 6.54% |
| Global Health Limited | ₹38,911 Cr | 67.98 | 9.82 | 14.05% | 11.88% |
| Narayana Hrudayalaya Ltd. | ₹38,199 Cr | 44.31 | 8.41 | 17.76% | 9% |
| Krishna Institute of Medical Sciences Ltd. | ₹32,296 Cr | 154.72 | 8.62 | 10.74% | 4.85% |
| Dr. Lal Path Labs Ltd. | ₹32,042 Cr | 56.97 | 12.78 | 20.13% | 18.75% |
| Poly Medicure Ltd. | ₹17,613 Cr | 55.04 | 5.67 | 10.37% | 15.77% |
| Vijaya Diagnostic Centre Ltd.(this company) | ₹15,470 Cr | 82.53 | 16.17 | 18.07% | 21.87% |
AI analysis
AI-generated · google/gemini-2.5-flashVijaya Diagnostic Centre Ltd. is listed with a market capitalization of Rs 13,802 Cr. The company reported a revenue of Rs 699.71 Cr and an EPS of Rs 14.01. The 52-week high for the share price was Rs 1440 and the 52-week low was Rs 848.
Positives
- +The Return on Equity (ROE) is 19.8%, indicating a relatively efficient use of shareholder funds.
- +The Return on Capital Employed (ROCE) is 19.266%, suggesting efficient capital utilization.
- +The debt-to-equity ratio is 0.4, indicating a manageable level of debt.
Negatives
- −Promoter shareholding has decreased from 55.0357% in June 2022 to 52.4652% in June 2026.
- −1.96% of promoter shares were pledged as of June 30, 2026, which includes 260,000 shares by Suprita Sura Reddy and 800,000 shares by Sunil Chandra Kondapally.
- −The Price-to-Earnings (PE) ratio of 72.22 is higher than the EPS of Rs 14.01.
- −The company has not disclosed quarterly results after Mar 2026.
Financial performance
For the period ending Mar 2025, Vijaya Diagnostic Centre Ltd. recorded a revenue of Rs 699.7096 Cr and a net profit of Rs 143.0753 Cr. Quarterly revenue for Mar 2026 was Rs 219.38 Cr, with a net profit of Rs 47.93 Cr. This follows revenues of Rs 205.21 Cr and net profit of Rs 43.18 Cr in Dec 2025, and Rs 201.56 Cr revenue with net profit of Rs 43.28 Cr in Sept 2025.
Profitability & Returns
The company’s Return on Equity (ROE) stands at 19.8% and Return on Capital Employed (ROCE) is 19.266%. The earnings per share (EPS) is Rs 14.01. The Price-to-Earnings (PE) ratio is 72.22, with a book value of Rs 77.53.
Balance Sheet
Vijaya Diagnostic Centre Ltd. has a debt-to-equity ratio of 0.4. This indicates the company's reliance on debt financing relative to equity. No details on other balance sheet items were provided.
Ownership & Pledges
As of June 30, 2026, promoters held 52.4652% of the company's shares. Foreign Institutional Investors (FIIs) held 11.6467%, while Domestic Institutional Investors (DIIs) held 31.5776%. The public shareholding was 4.3105%. A total of 1.96% of promoter shares were pledged as of June 30, 2026, including 260,000 shares (2.9% of total) by Suprita Sura Reddy and 800,000 shares (10.29% of total) by Sunil Chandra Kondapally.
Shareholding History
Promoter shareholding has decreased from 55.0357% in June 2022 to 52.4652% in June 2026. FII holding has shown fluctuations, from 27.9935% in June 2022 to 11.6467% in June 2026. DII holding has increased from 12.7569% in June 2022 to 31.5776% in June 2026.
Data as of — price: 2026-09-12 · financials: Jun 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Vijaya Diagnostic Centre Ltd.share price & fundamentals